Below are the most recent publications written about "Psychotic Disorders" by people in Profiles.
-
Salisbury DF, Curtis M, Longenecker J, Yeh FC, Kim T, Coffman BA. Pathological resting-state executive and language system perfusion in first-episode psychosis. Neuroimage Clin. 2022; 36:103261.
-
Citrome L, Preskorn SH, Lauriello J, Krystal JH, Kakar R, Finman J, De Vivo M, Yocca FD, Risinger R, Rajachandran L. Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial. J Clin Psychiatry. 2022 10 03; 83(6).
-
Curtis MT, Ren X, Coffman BA, Salisbury DF. Attentional M100 gain modulation localizes to auditory sensory cortex and is deficient in first-episode psychosis. Hum Brain Mapp. 2023 01; 44(1):218-228.
-
Miranda M, Harmuth F, Bustamante ML, Rossi M, Sturm M, Magnusson ?T, Bauer P, Klockgether T, Ramirez A. Intermediate phenotype of ATP13A2 mutation in two Chilean siblings: Towards a continuum between parkinsonism and hereditary spastic paraplegia. Parkinsonism Relat Disord. 2020 12; 81:45-47.
-
Luttrull MD, Boulter DJ, Kirsch CFE, Aulino JM, Broder JS, Chakraborty S, Choudhri AF, Ducruet AF, Kendi AT, Lee RK, Liebeskind DS, Mack W, Moritani T, Roca RP, Shah LM, Sharma A, Shih RY, Symko SC, Bykowski J. ACR Appropriateness Criteria? Acute Mental Status Change, Delirium, and New Onset Psychosis. J Am Coll Radiol. 2019 May; 16(5S):S26-S37.
-
Thippaiah SM, Nagaraja S, Birur B, Cohen AW. An Interesting Presentation About Cyclical Menstrual Psychosis with an Updated Review of Literature. Psychopharmacol Bull. 2018 03 13; 48(3):16-21.
-
Scott KM, Saha S, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bromet EJ, Bruffaerts R, Caldas-de-Almeida JM, de Girolamo G, de Jonge P, Degenhardt L, Florescu S, Gureje O, Haro JM, Hu C, Karam EG, Kovess-Masfety V, Lee S, Lepine JP, Mneimneh Z, Navarro-Mateu F, Piazza M, Posada-Villa J, Sampson NA, Stagnaro JC, Kessler RC, McGrath JJ. Psychotic experiences and general medical conditions: a cross-national analysis based on 28 002 respondents from 16 countries in the WHO World Mental Health Surveys. Psychol Med. 2018 12; 48(16):2730-2739.
-
Degenhardt L, Saha S, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Andrade LH, Bromet EJ, Bruffaerts R, Caldas-de-Almeida JM, de Girolamo G, Florescu S, Gureje O, Haro JM, Karam EG, Karam G, Kovess-Masfety V, Lee S, Lepine JP, Makanjuola V, Medina-Mora ME, Mneimneh Z, Navarro-Mateu F, Piazza M, Posada-Villa J, Sampson NA, Scott KM, Stagnaro JC, Ten Have M, Kendler KS, Kessler RC, McGrath JJ. The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys. Addiction. 2018 05; 113(5):924-934.
-
McGrath JJ, Saha S, Lim CCW, Aguilar-Gaxiola S, Alonso J, Andrade LH, Bromet EJ, Bruffaerts R, Caldas de Almeida JM, Cardoso G, de Girolamo G, Fayyad J, Florescu S, Gureje O, Haro JM, Kawakami N, Koenen KC, Kovess-Masfety V, Lee S, Lepine JP, McLaughlin KA, Medina-Mora ME, Navarro-Mateu F, Ojagbemi A, Posada-Villa J, Sampson N, Scott KM, Tachimori H, Ten Have M, Kendler KS, Kessler RC. Trauma and psychotic experiences: transnational data from the World Mental Health Survey. Br J Psychiatry. 2017 Dec; 211(6):373-380.
-
Foster A, Buckley P, Lauriello J, Looney S, Schooler N. Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial. J Clin Psychopharmacol. 2017 Oct; 37(5):595-599.